News
- October 31, 2011
- Martin LeBlanc interview in La Presse newspaper (in French) (PDF)
- October 21, 2010
- Caprion Proteomics identifies promising new candidate biomarkers to predict response to hepatitis C treatment
- March 25, 2009
- Caprion article in Genetic Engineering & biotechnology News: "Personalized Medicine Grows in Fits and Starts" March 1st 2009 issue (Volume 29, Number 5)
- December 16, 2008
- Caprion Proteomics inc. announces strategic marketing and distribution alliance with Covance inc.
- December 16, 2008
- Covance purchases equity stake in Caprion Proteomics
- December 13, 2008
- Dr Joanna Hunter featured as one of the 8 most indispensable business women in Québec, by Premieres en affaires.com
- October 3, 2008
- The National Institute of Allergy and Infectious Diseases (NIAID) a part of the US National Institutes of Health, awards Caprion a $12.9M US Infectious Disease Biomarker Research Contract. (PDF)
- July 11, 2008
- Drug Discovery & Development magizine article - July 01, 2008 "Genes lead to proteins, yes, but there's something more beyond translation. You need the protein sequence."
- January 15, 2008
- Caprion article in Genetic Engineering & biotechnology News: "Capitalizing on Biomarker Discovery Work" January 15th 2008 issue (Volume 28, Number 2)
- January 1, 2008
- Caprion article in Genetic Engineering & biotechnology News: "Unlocking the Secrets of Protein Profiling" January 1st 2008 issue (Volume 28, Number 1)
- July 11, 2007
- Great Point Partners announce acquisition of a majority stake in Caprion Proteomics.
- June 28, 2007
- Thallion Announces Sale of Majority Stake in Caprion Proteomics to Great Point Partners
- June 6, 2007
- Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
- March 13, 2007
- Caprion and Ecopia complete combination and announce closing of $45 million private placement: New entity called Thallion Pharmaceuticals Inc. Caprion Proteomics is established.
- March 12, 2007
- Caprion and Ecopia Shareholders Approve Amalgamation and Related Transactions
- February 19, 2007
- Caprion and Ecopia Announce Commitments of $45 Million in Connection with Private Placement
- January 4, 2007
- Ecopia announces agreement with caprion to combine their businesses and launch a $30 million private placement
- October 25, 2006
- Caprion Pharmaceuticals Announces Expansion of Biomarker Discovery Collaboration with Vertex Pharmaceuticals
- October 11, 2006
- Caprion Pharmaceuticals Enters Into Oncology Target Licensing Agreement with Centocor Research and Development, Inc.
- September 22, 2006
- Caprion Pharmaceuticals Inc. Named One of Canadas Fastest Growing Companies in 2006 Deloitte Life Sciences Fast 15 Program
- September 19, 2006
- Caprion Announces Completion of Phase I Clinical Studies for its Shigatoxin-producing E. coli Therapy
- March 29, 2006
- Caprion Pharmaceuticals Announces New Biomarker Discovery Collaboration with Vertex Pharmaceuticals
- January 24, 2006
- Caprion Pharmaceuticals Announces Biomarker Discovery Collaboration with Berlex Biosciences
- January 18, 2006
- Caprion Pharmaceuticals Announces Biomarker Discovery Collaboration with ICOS Corporation
- January 10, 2006
- Caprion Pharmaceuticals Enters Into Oncology Target Licensing Agreement with ImClone Systems
- November 1, 2005
- Caprion Pharmaceuticals Announces New Collabration With AstraZeneca
- July 12, 2005
- Caprion Pharmaceuticals Announces Biomarker Research Collaboration With Boehringer Ingelheim
- June 28, 2005
- Wyeth Expands Caprion Biomarker Collaborations to Include Two Clinical Biomarker Programs
- March 31, 2005
- ICOS Corporation And Caprion Pharmaceuticals Enter Into Joint Development Collaboration
- March 21, 2005
- Caprion completes key milestone early in Oncology Discovery collaboration with Abbott
- June 7, 2004
- Caprion Pharmaceuticals acquires therapeutic antibody clinical program and antibody technologies from Sunol Molecular
- February 4, 2004
- Abbott Laboratories And Caprion Pharmaceuticals Announce Drug Discovery Collaboration In Oncology
- September 24, 2003
- New discovery provides a basis for the development of more effective vaccines against infectious disease and cancer
- August 11, 2003
- Caprion Pharmaceuticals Announces Disease Biomarker Research Collaboration with AstraZeneca
- July 16, 2003
- Caprion Pharmaceuticals and Wyeth Announce Biomarker Research Collaboration
- June 1, 2003
- Researchers Discover Possible Diagnostic, Therapy, Vaccine For Mad Cow and Other Prion Diseases
